| Cat.No. |
Chemical Name |
MolFormula |
| HR253974 |
Olmesartan Medoxomil Impurity G |
|
| HR253973 |
Olmesartan Ethyl Ester Trityl Impurity |
C45H44N6O3 |
| HR253358 |
Octyl 2,3,4,6-tetra-O-acetyl-b-Dglucopyranoside |
C22H36O10 |
| HR253153 |
O-Desmethyl Tramadol |
|
| HR252627 |
Oxymetazoline EP Impurity D |
|
| HR252626 |
Oxymetazoline EP Impurity C |
|
| HR252624 |
Oxybutynin N-Oxide |
|
| HR252623 |
Oxcarbazepine EP Impurity D |
|
| HR252622 |
1,9-Bis(4-fluorophenyl)nonane-1,5,9-trione |
C21H20F2O3 |
| HR252620 |
Ospemifene E-Isomer |
|
| HR252619 |
Ospemifene Impurity 2 |
|
| HR252617 |
Oseltamivir EP Impurity E (Oseltamivir Acid Methyl Ester) |
|
| HR252616 |
Oseltamivir EP Impurity A |
|
| HR252614 |
Ornidazole 4-Nitro Isomer |
|
| HR252613 |
Ondansetron EP Impurity B/ Ondansetron Related Compound B (Ondansetron Dimer) |
|
| HR252608 |
Omeprazole N-Methyl 5-Methoxy Analog |
|
| HR252606 |
Omeprazole 4-Desmethyl Impurity |
|
| HR252605 |
Omeprazole EP Impurity G/ Omeprazole Related Compound G |
|
| HR252604 |
Omeprazole EP Impurity F/ Omeprazole Related Compound F |
|
| HR252602 |
Olopatadine Hydroxy Derivative |
|
| HR252601 |
Olopatadine Ethyl Ester |
|
| HR252600 |
Olopatadine Isopropyl Ester |
|
| HR252598 |
Olmesartan Dimer Ester |
|
| HR252596 |
Olmesartan Ethyl Ester N2-Trityl Analog |
|
| HR252594 |
Olmesartan Medoxomil Ethyl Analog/ Ethyl Olmesartan Medoxomil |
|
| HR252593 |
Olmesartan Methyl Ether/ O-Methyl Olmesartan Acid |
|
| HR252591 |
Olmesartan Medoxomil Methyl Ether/ Olmesartan Medoxomil O-Methyl Analog |
|
| HR252589 |
Olmesartan ethyl ester N-1 trityl analog |
C90H88N12O6 |
| HR252588 |
Olmesartan Ethyl methyl impurity |
|
| HR252586 |
Olmesartan Anhydro Acid N2-Trityl Ethyl Ester |
|
